BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 18376421)

  • 21. [Sentinel node biopsy in melanoma: an update].
    Botella-Estrada R; Nagore E
    Actas Dermosifiliogr; 2011 Dec; 102(10):749-53. PubMed ID: 21640960
    [No Abstract]   [Full Text] [Related]  

  • 22. Prediction of nonsentinel lymph node metastasis in malignant melanoma.
    Cadili A; Smylie M; Danyluk J; Dabbs K
    J Surg Res; 2009 Jun; 154(2):324-9. PubMed ID: 19101696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymph node assessment in melanoma.
    Easson AM; Rotstein LE; McCready DR
    J Surg Oncol; 2009 Mar; 99(4):176-85. PubMed ID: 19065639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can completion lymph node dissection be avoided for a positive sentinel node in melanoma?
    Morton DL; Scheri RP; Balch CM
    Ann Surg Oncol; 2007 Sep; 14(9):2437-9. PubMed ID: 17574500
    [No Abstract]   [Full Text] [Related]  

  • 25. Sentinel node biopsy for melanoma: unnecessary treatment?
    Torjesen I
    BMJ; 2013 Jan; 346():e8645. PubMed ID: 23299845
    [No Abstract]   [Full Text] [Related]  

  • 26. Prognostic factors of cutaneous melanoma in relation to metastasis at the sentinel lymph node: a case-controlled study.
    Sartore L; Papanikolaou GE; Biancari F; Mazzoleni F
    Int J Surg; 2008 Jun; 6(3):205-9. PubMed ID: 18417434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sentinel lymph node biopsy: sentinel node technique has drawbacks.
    Ciatto S
    BMJ; 2004 Jul; 329(7458):170. PubMed ID: 15258080
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database.
    Mandalà M; Imberti GL; Piazzalunga D; Belfiglio M; Labianca R; Barberis M; Marchesi L; Poletti P; Bonomi L; Novellino L; Di Biagio K; Milesi A; Guerra U; Tondini C
    Eur J Cancer; 2009 Sep; 45(14):2537-45. PubMed ID: 19553103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mitotic rate and sentinel lymph node tumor burden topography: integration into melanoma staging and stratification use in clinical trials.
    Averbook BJ
    J Clin Oncol; 2011 Jun; 29(16):2137-41. PubMed ID: 21519024
    [No Abstract]   [Full Text] [Related]  

  • 30. Sentinel-node biopsy in melanoma.
    A'Hern RP
    N Engl J Med; 2007 Jan; 356(4):418; author reply 419-21. PubMed ID: 17256189
    [No Abstract]   [Full Text] [Related]  

  • 31. Prognostic value of sentinel lymph node biopsy.
    Shaw HM; Thompson JF
    Br J Dermatol; 2007 Aug; 157(2):405. PubMed ID: 17573881
    [No Abstract]   [Full Text] [Related]  

  • 32. Freedom of expression or protectionism in the debate on sentinel node biopsy in melanoma.
    Thomas JM
    J Am Acad Dermatol; 2009 Dec; 61(6):1079. PubMed ID: 19925932
    [No Abstract]   [Full Text] [Related]  

  • 33. [The method of the sentinel lymph node].
    Testori A
    Chir Ital; 2002; 54(5):759-60. PubMed ID: 12469474
    [No Abstract]   [Full Text] [Related]  

  • 34. Concerns relating to the conduct and statistical analysis of the Multicenter Selective Lymphadenectomy Trial (MSLT-1) in patients with melanoma.
    Thomas JM
    J Plast Reconstr Aesthet Surg; 2009 Apr; 62(4):442-6. PubMed ID: 19246272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimal detection of sentinel lymph node metastases by intraoperative radioactive threshold and molecular analysis in patients with melanoma.
    Manca G; Romanini A; Pellegrino D; Borsò E; Rondini M; Orlandini C; Zucchi V; Pasqualetti F; Mariani G
    J Nucl Med; 2008 Nov; 49(11):1769-75. PubMed ID: 18927334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sentinel lymph node micrometastasis may predict non-sentinel involvement in cutaneous melanoma patients.
    Glumac N; Hocevar M; Zadnik V; Snoj M
    J Surg Oncol; 2008 Jul; 98(1):46-8. PubMed ID: 18452214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Surgical technique and postoperative morbidity following radical inguinal/iliacal lymph node dissection--a prospective study in 67 patients with malignant melanoma metastatic to the groin].
    Mall JW; Reetz C; Koplin G; Schäfer-Hesterberg G; Voit C; Neuss H
    Zentralbl Chir; 2009 Sep; 134(5):437-42. PubMed ID: 19757344
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathology of sentinel lymph nodes for melanoma.
    Cook MG; Di Palma S
    J Clin Pathol; 2008 Aug; 61(8):897-902. PubMed ID: 18515403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sentinel lymphadenectomy for cutaneous melanoma: who, what, and why.
    Bower M; Scoggins CR
    J Ky Med Assoc; 2009 Jul; 107(7):253-8. PubMed ID: 19678500
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Viewpoint of the Dutch Melanoma Working Group regarding sentinel lymph node biopsy: prognostic but not therapeutic implications].
    Kruit WH;
    Ned Tijdschr Geneeskd; 2008 Mar; 152(10):574-6. PubMed ID: 18402325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.